Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults

Vaccine ◽  
2015 ◽  
Vol 33 (24) ◽  
pp. 2793-2799 ◽  
Author(s):  
Richard McFetridge ◽  
Ajoke Sobanjo-ter Meulen ◽  
Steven D. Folkerth ◽  
John A. Hoekstra ◽  
Michael Dallas ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Healthy Adults

scholarly journals Carriage ofStreptoccoccus pneumoniaein healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children

2013 ◽  
Vol 9 (3) ◽  
pp. 614-620 ◽  
Author(s):  
Filippo Ansaldi ◽  
Daniela de Florentiis ◽  
Paola Canepa ◽  
Antonella Ceravolo ◽  
Emanuela Rappazzo ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Vaccine Coverage ◽  
Healthy Adults ◽  
Very High

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

Vaccine ◽  
2007 ◽  
Vol 25 (33) ◽  
pp. 6164-6166 ◽  
Author(s):  
Daniel A. Scott ◽  
Steven F. Komjathy ◽  
Branda T. Hu ◽  
Sherryl Baker ◽  
Lois A. Supan ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Phase 1 ◽  
Healthy Adults ◽  
Phase 1 Trial

Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults

Vaccine ◽  
2019 ◽  
Vol 37 (42) ◽  
pp. 6201-6207 ◽  
Author(s):  
Allison Thompson ◽  
Erik Lamberth ◽  
Joseph Severs ◽  
Ingrid Scully ◽  
Sanela Tarabar ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Phase 1 ◽  
Healthy Adults ◽  
Phase 1 Trial
Sign in / Sign up

Export Citation Format

Share Document